| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |